금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Diesel Crisis Threatens to Outlast the Middle East War
The outlook for the Middle East war remains grim, the U.S. just threatened Iran with the “toughest s...
Stock futures slip as U.S. and Canada appear headed for trade war
U.S. stock-index futures dipped on Sunday, as it appeared the U.S. was on the verge of an all-out tr...
An economic D-Day is coming for Iran
Countries that calculate appeasement of the regime to be a safer choice should reconsider...
Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Ulta Beauty (ULTA) stood at $543.86, denoting a +1.77% move from the preceding trading day.
Toll Brothers (TOL) Exceeds Market Returns: Some Facts to Consider
The latest trading day saw Toll Brothers (TOL) settling at $153.24, representing a +1.85% change from its previous close.
Lowe's (LOW) Laps the Stock Market: Here's Why
Lowe's (LOW) concluded the recent trading session at $218.08, signifying a +2.84% move from its prior day's close.
Intuit (INTU) Advances But Underperforms Market: Key Facts
In the closing of the recent trading day, Intuit (INTU) stood at $323.6, denoting a +1.64% move from the preceding trading day.
Macy's (M) Gains But Lags Market: What You Should Know
In the closing of the recent trading day, Macy's (M) stood at $26.21, denoting a +1% move from the preceding trading day.
Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing
Home Depot (HD) concluded the recent trading session at $348.24, signifying a +2.42% move from its prior day's close.
Why Gold.com (GOLD) Outpaced the Stock Market Today
The latest trading day saw Gold.com (GOLD) settling at $42.9, representing a +1.83% change from its previous close.
Charlie’s Holdings names Henry Sicignano as CEO ahead of age-gated vape launch
Gold gains as lower oil prices, lackluster U.S. jobs data ease inflation fears
Stride GAAP EPS of $7.14 beats by $0.07, revenue of $2.52B beats by $10M
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.
Par Pacific earnings surge on strong refining margins amid turnaround